<html xmlns:v="urn:schemas-microsoft-com:vml"
xmlns:o="urn:schemas-microsoft-com:office:office"
xmlns:w="urn:schemas-microsoft-com:office:word"
xmlns:m="http://schemas.microsoft.com/office/2004/12/omml"
xmlns="http://www.w3.org/TR/REC-html40">

<head>
<meta http-equiv=Content-Type content="text/html; charset=utf-8">
<meta name=ProgId content=Word.Document>
<meta name=Generator content="Microsoft Word 15">
<meta name=Originator content="Microsoft Word 15">
<link rel=File-List href="PBYI%208E.fld/filelist.xml">
<link rel=Edit-Time-Data href="PBYI%208E.fld/editdata.mso">
<link rel=OLE-Object-Data href="PBYI%208E.fld/oledata.mso">
<!--[if !mso]>
<style>
v\:* {behavior:url(#default#VML);}
o\:* {behavior:url(#default#VML);}
w\:* {behavior:url(#default#VML);}
.shape {behavior:url(#default#VML);}
</style>
<![endif]--><!--[if gte mso 9]><xml>
 <o:DocumentProperties>
  <o:Author>Microsoft Office User</o:Author>
  <o:LastAuthor>Microsoft Office User</o:LastAuthor>
  <o:Revision>2</o:Revision>
  <o:TotalTime>0</o:TotalTime>
  <o:Created>2019-05-31T14:58:00Z</o:Created>
  <o:LastSaved>2019-05-31T14:58:00Z</o:LastSaved>
  <o:Pages>9</o:Pages>
  <o:Words>1083</o:Words>
  <o:Characters>6176</o:Characters>
  <o:Lines>51</o:Lines>
  <o:Paragraphs>14</o:Paragraphs>
  <o:CharactersWithSpaces>7245</o:CharactersWithSpaces>
  <o:Version>16.00</o:Version>
 </o:DocumentProperties>
 <o:OfficeDocumentSettings>
  <o:AllowPNG/>
 </o:OfficeDocumentSettings>
</xml><![endif]-->
<link rel=dataStoreItem href="PBYI%208E.fld/item0001.xml"
target="PBYI%208E.fld/props002.xml">
<link rel=themeData href="PBYI%208E.fld/themedata.thmx">
<link rel=colorSchemeMapping href="PBYI%208E.fld/colorschememapping.xml">
<!--[if gte mso 9]><xml>
 <w:WordDocument>
  <w:SpellingState>Clean</w:SpellingState>
  <w:GrammarState>Clean</w:GrammarState>
  <w:TrackMoves>false</w:TrackMoves>
  <w:TrackFormatting/>
  <w:PunctuationKerning/>
  <w:ValidateAgainstSchemas/>
  <w:SaveIfXMLInvalid>false</w:SaveIfXMLInvalid>
  <w:IgnoreMixedContent>false</w:IgnoreMixedContent>
  <w:AlwaysShowPlaceholderText>false</w:AlwaysShowPlaceholderText>
  <w:DoNotPromoteQF/>
  <w:LidThemeOther>EN-US</w:LidThemeOther>
  <w:LidThemeAsian>JA</w:LidThemeAsian>
  <w:LidThemeComplexScript>X-NONE</w:LidThemeComplexScript>
  <w:Compatibility>
   <w:BreakWrappedTables/>
   <w:SnapToGridInCell/>
   <w:WrapTextWithPunct/>
   <w:UseAsianBreakRules/>
   <w:DontGrowAutofit/>
   <w:SplitPgBreakAndParaMark/>
   <w:EnableOpenTypeKerning/>
   <w:DontFlipMirrorIndents/>
   <w:OverrideTableStyleHps/>
  </w:Compatibility>
  <m:mathPr>
   <m:mathFont m:val="Cambria Math"/>
   <m:brkBin m:val="before"/>
   <m:brkBinSub m:val="&#45;-"/>
   <m:smallFrac m:val="off"/>
   <m:dispDef/>
   <m:lMargin m:val="0"/>
   <m:rMargin m:val="0"/>
   <m:defJc m:val="centerGroup"/>
   <m:wrapIndent m:val="1440"/>
   <m:intLim m:val="subSup"/>
   <m:naryLim m:val="undOvr"/>
  </m:mathPr></w:WordDocument>
</xml><![endif]--><!--[if gte mso 9]><xml>
 <w:LatentStyles DefLockedState="false" DefUnhideWhenUsed="false"
  DefSemiHidden="false" DefQFormat="false" DefPriority="99"
  LatentStyleCount="375">
  <w:LsdException Locked="false" Priority="0" QFormat="true" Name="Normal"/>
  <w:LsdException Locked="false" Priority="9" QFormat="true" Name="heading 1"/>
  <w:LsdException Locked="false" Priority="9" SemiHidden="true"
   UnhideWhenUsed="true" QFormat="true" Name="heading 2"/>
  <w:LsdException Locked="false" Priority="9" SemiHidden="true"
   UnhideWhenUsed="true" QFormat="true" Name="heading 3"/>
  <w:LsdException Locked="false" Priority="9" SemiHidden="true"
   UnhideWhenUsed="true" QFormat="true" Name="heading 4"/>
  <w:LsdException Locked="false" Priority="9" SemiHidden="true"
   UnhideWhenUsed="true" QFormat="true" Name="heading 5"/>
  <w:LsdException Locked="false" Priority="9" SemiHidden="true"
   UnhideWhenUsed="true" QFormat="true" Name="heading 6"/>
  <w:LsdException Locked="false" Priority="9" SemiHidden="true"
   UnhideWhenUsed="true" QFormat="true" Name="heading 7"/>
  <w:LsdException Locked="false" Priority="9" SemiHidden="true"
   UnhideWhenUsed="true" QFormat="true" Name="heading 8"/>
  <w:LsdException Locked="false" Priority="9" SemiHidden="true"
   UnhideWhenUsed="true" QFormat="true" Name="heading 9"/>
  <w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true"
   Name="index 1"/>
  <w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true"
   Name="index 2"/>
  <w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true"
   Name="index 3"/>
  <w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true"
   Name="index 4"/>
  <w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true"
   Name="index 5"/>
  <w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true"
   Name="index 6"/>
  <w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true"
   Name="index 7"/>
  <w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true"
   Name="index 8"/>
  <w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true"
   Name="index 9"/>
  <w:LsdException Locked="false" Priority="39" SemiHidden="true"
   UnhideWhenUsed="true" Name="toc 1"/>
  <w:LsdException Locked="false" Priority="39" SemiHidden="true"
   UnhideWhenUsed="true" Name="toc 2"/>
  <w:LsdException Locked="false" Priority="39" SemiHidden="true"
   UnhideWhenUsed="true" Name="toc 3"/>
  <w:LsdException Locked="false" Priority="39" SemiHidden="true"
   UnhideWhenUsed="true" Name="toc 4"/>
  <w:LsdException Locked="false" Priority="39" SemiHidden="true"
   UnhideWhenUsed="true" Name="toc 5"/>
  <w:LsdException Locked="false" Priority="39" SemiHidden="true"
   UnhideWhenUsed="true" Name="toc 6"/>
  <w:LsdException Locked="false" Priority="39" SemiHidden="true"
   UnhideWhenUsed="true" Name="toc 7"/>
  <w:LsdException Locked="false" Priority="39" SemiHidden="true"
   UnhideWhenUsed="true" Name="toc 8"/>
  <w:LsdException Locked="false" Priority="39" SemiHidden="true"
   UnhideWhenUsed="true" Name="toc 9"/>
  <w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true"
   Name="Normal Indent"/>
  <w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true"
   Name="footnote text"/>
  <w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true"
   Name="annotation text"/>
  <w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true"
   Name="header"/>
  <w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true"
   Name="footer"/>
  <w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true"
   Name="index heading"/>
  <w:LsdException Locked="false" Priority="35" SemiHidden="true"
   UnhideWhenUsed="true" QFormat="true" Name="caption"/>
  <w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true"
   Name="table of figures"/>
  <w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true"
   Name="envelope address"/>
  <w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true"
   Name="envelope return"/>
  <w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true"
   Name="footnote reference"/>
  <w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true"
   Name="annotation reference"/>
  <w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true"
   Name="line number"/>
  <w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true"
   Name="page number"/>
  <w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true"
   Name="endnote reference"/>
  <w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true"
   Name="endnote text"/>
  <w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true"
   Name="table of authorities"/>
  <w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true"
   Name="macro"/>
  <w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true"
   Name="toa heading"/>
  <w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true"
   Name="List"/>
  <w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true"
   Name="List Bullet"/>
  <w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true"
   Name="List Number"/>
  <w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true"
   Name="List 2"/>
  <w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true"
   Name="List 3"/>
  <w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true"
   Name="List 4"/>
  <w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true"
   Name="List 5"/>
  <w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true"
   Name="List Bullet 2"/>
  <w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true"
   Name="List Bullet 3"/>
  <w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true"
   Name="List Bullet 4"/>
  <w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true"
   Name="List Bullet 5"/>
  <w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true"
   Name="List Number 2"/>
  <w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true"
   Name="List Number 3"/>
  <w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true"
   Name="List Number 4"/>
  <w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true"
   Name="List Number 5"/>
  <w:LsdException Locked="false" Priority="10" QFormat="true" Name="Title"/>
  <w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true"
   Name="Closing"/>
  <w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true"
   Name="Signature"/>
  <w:LsdException Locked="false" Priority="1" SemiHidden="true"
   UnhideWhenUsed="true" Name="Default Paragraph Font"/>
  <w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true"
   Name="Body Text"/>
  <w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true"
   Name="Body Text Indent"/>
  <w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true"
   Name="List Continue"/>
  <w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true"
   Name="List Continue 2"/>
  <w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true"
   Name="List Continue 3"/>
  <w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true"
   Name="List Continue 4"/>
  <w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true"
   Name="List Continue 5"/>
  <w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true"
   Name="Message Header"/>
  <w:LsdException Locked="false" Priority="11" QFormat="true" Name="Subtitle"/>
  <w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true"
   Name="Salutation"/>
  <w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true"
   Name="Date"/>
  <w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true"
   Name="Body Text First Indent"/>
  <w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true"
   Name="Body Text First Indent 2"/>
  <w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true"
   Name="Note Heading"/>
  <w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true"
   Name="Body Text 2"/>
  <w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true"
   Name="Body Text 3"/>
  <w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true"
   Name="Body Text Indent 2"/>
  <w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true"
   Name="Body Text Indent 3"/>
  <w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true"
   Name="Block Text"/>
  <w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true"
   Name="Hyperlink"/>
  <w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true"
   Name="FollowedHyperlink"/>
  <w:LsdException Locked="false" Priority="22" QFormat="true" Name="Strong"/>
  <w:LsdException Locked="false" Priority="20" QFormat="true" Name="Emphasis"/>
  <w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true"
   Name="Document Map"/>
  <w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true"
   Name="Plain Text"/>
  <w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true"
   Name="E-mail Signature"/>
  <w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true"
   Name="HTML Top of Form"/>
  <w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true"
   Name="HTML Bottom of Form"/>
  <w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true"
   Name="Normal (Web)"/>
  <w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true"
   Name="HTML Acronym"/>
  <w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true"
   Name="HTML Address"/>
  <w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true"
   Name="HTML Cite"/>
  <w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true"
   Name="HTML Code"/>
  <w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true"
   Name="HTML Definition"/>
  <w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true"
   Name="HTML Keyboard"/>
  <w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true"
   Name="HTML Preformatted"/>
  <w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true"
   Name="HTML Sample"/>
  <w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true"
   Name="HTML Typewriter"/>
  <w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true"
   Name="HTML Variable"/>
  <w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true"
   Name="Normal Table"/>
  <w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true"
   Name="annotation subject"/>
  <w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true"
   Name="No List"/>
  <w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true"
   Name="Outline List 1"/>
  <w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true"
   Name="Outline List 2"/>
  <w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true"
   Name="Outline List 3"/>
  <w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true"
   Name="Table Simple 1"/>
  <w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true"
   Name="Table Simple 2"/>
  <w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true"
   Name="Table Simple 3"/>
  <w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true"
   Name="Table Classic 1"/>
  <w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true"
   Name="Table Classic 2"/>
  <w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true"
   Name="Table Classic 3"/>
  <w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true"
   Name="Table Classic 4"/>
  <w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true"
   Name="Table Colorful 1"/>
  <w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true"
   Name="Table Colorful 2"/>
  <w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true"
   Name="Table Colorful 3"/>
  <w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true"
   Name="Table Columns 1"/>
  <w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true"
   Name="Table Columns 2"/>
  <w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true"
   Name="Table Columns 3"/>
  <w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true"
   Name="Table Columns 4"/>
  <w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true"
   Name="Table Columns 5"/>
  <w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true"
   Name="Table Grid 1"/>
  <w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true"
   Name="Table Grid 2"/>
  <w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true"
   Name="Table Grid 3"/>
  <w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true"
   Name="Table Grid 4"/>
  <w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true"
   Name="Table Grid 5"/>
  <w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true"
   Name="Table Grid 6"/>
  <w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true"
   Name="Table Grid 7"/>
  <w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true"
   Name="Table Grid 8"/>
  <w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true"
   Name="Table List 1"/>
  <w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true"
   Name="Table List 2"/>
  <w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true"
   Name="Table List 3"/>
  <w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true"
   Name="Table List 4"/>
  <w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true"
   Name="Table List 5"/>
  <w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true"
   Name="Table List 6"/>
  <w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true"
   Name="Table List 7"/>
  <w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true"
   Name="Table List 8"/>
  <w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true"
   Name="Table 3D effects 1"/>
  <w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true"
   Name="Table 3D effects 2"/>
  <w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true"
   Name="Table 3D effects 3"/>
  <w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true"
   Name="Table Contemporary"/>
  <w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true"
   Name="Table Elegant"/>
  <w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true"
   Name="Table Professional"/>
  <w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true"
   Name="Table Subtle 1"/>
  <w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true"
   Name="Table Subtle 2"/>
  <w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true"
   Name="Table Web 1"/>
  <w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true"
   Name="Table Web 2"/>
  <w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true"
   Name="Table Web 3"/>
  <w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true"
   Name="Balloon Text"/>
  <w:LsdException Locked="false" Priority="39" Name="Table Grid"/>
  <w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true"
   Name="Table Theme"/>
  <w:LsdException Locked="false" SemiHidden="true" Name="Placeholder Text"/>
  <w:LsdException Locked="false" Priority="1" QFormat="true" Name="No Spacing"/>
  <w:LsdException Locked="false" Priority="60" Name="Light Shading"/>
  <w:LsdException Locked="false" Priority="61" Name="Light List"/>
  <w:LsdException Locked="false" Priority="62" Name="Light Grid"/>
  <w:LsdException Locked="false" Priority="63" Name="Medium Shading 1"/>
  <w:LsdException Locked="false" Priority="64" Name="Medium Shading 2"/>
  <w:LsdException Locked="false" Priority="65" Name="Medium List 1"/>
  <w:LsdException Locked="false" Priority="66" Name="Medium List 2"/>
  <w:LsdException Locked="false" Priority="67" Name="Medium Grid 1"/>
  <w:LsdException Locked="false" Priority="68" Name="Medium Grid 2"/>
  <w:LsdException Locked="false" Priority="69" Name="Medium Grid 3"/>
  <w:LsdException Locked="false" Priority="70" Name="Dark List"/>
  <w:LsdException Locked="false" Priority="71" Name="Colorful Shading"/>
  <w:LsdException Locked="false" Priority="72" Name="Colorful List"/>
  <w:LsdException Locked="false" Priority="73" Name="Colorful Grid"/>
  <w:LsdException Locked="false" Priority="60" Name="Light Shading Accent 1"/>
  <w:LsdException Locked="false" Priority="61" Name="Light List Accent 1"/>
  <w:LsdException Locked="false" Priority="62" Name="Light Grid Accent 1"/>
  <w:LsdException Locked="false" Priority="63" Name="Medium Shading 1 Accent 1"/>
  <w:LsdException Locked="false" Priority="64" Name="Medium Shading 2 Accent 1"/>
  <w:LsdException Locked="false" Priority="65" Name="Medium List 1 Accent 1"/>
  <w:LsdException Locked="false" SemiHidden="true" Name="Revision"/>
  <w:LsdException Locked="false" Priority="34" QFormat="true"
   Name="List Paragraph"/>
  <w:LsdException Locked="false" Priority="29" QFormat="true" Name="Quote"/>
  <w:LsdException Locked="false" Priority="30" QFormat="true"
   Name="Intense Quote"/>
  <w:LsdException Locked="false" Priority="66" Name="Medium List 2 Accent 1"/>
  <w:LsdException Locked="false" Priority="67" Name="Medium Grid 1 Accent 1"/>
  <w:LsdException Locked="false" Priority="68" Name="Medium Grid 2 Accent 1"/>
  <w:LsdException Locked="false" Priority="69" Name="Medium Grid 3 Accent 1"/>
  <w:LsdException Locked="false" Priority="70" Name="Dark List Accent 1"/>
  <w:LsdException Locked="false" Priority="71" Name="Colorful Shading Accent 1"/>
  <w:LsdException Locked="false" Priority="72" Name="Colorful List Accent 1"/>
  <w:LsdException Locked="false" Priority="73" Name="Colorful Grid Accent 1"/>
  <w:LsdException Locked="false" Priority="60" Name="Light Shading Accent 2"/>
  <w:LsdException Locked="false" Priority="61" Name="Light List Accent 2"/>
  <w:LsdException Locked="false" Priority="62" Name="Light Grid Accent 2"/>
  <w:LsdException Locked="false" Priority="63" Name="Medium Shading 1 Accent 2"/>
  <w:LsdException Locked="false" Priority="64" Name="Medium Shading 2 Accent 2"/>
  <w:LsdException Locked="false" Priority="65" Name="Medium List 1 Accent 2"/>
  <w:LsdException Locked="false" Priority="66" Name="Medium List 2 Accent 2"/>
  <w:LsdException Locked="false" Priority="67" Name="Medium Grid 1 Accent 2"/>
  <w:LsdException Locked="false" Priority="68" Name="Medium Grid 2 Accent 2"/>
  <w:LsdException Locked="false" Priority="69" Name="Medium Grid 3 Accent 2"/>
  <w:LsdException Locked="false" Priority="70" Name="Dark List Accent 2"/>
  <w:LsdException Locked="false" Priority="71" Name="Colorful Shading Accent 2"/>
  <w:LsdException Locked="false" Priority="72" Name="Colorful List Accent 2"/>
  <w:LsdException Locked="false" Priority="73" Name="Colorful Grid Accent 2"/>
  <w:LsdException Locked="false" Priority="60" Name="Light Shading Accent 3"/>
  <w:LsdException Locked="false" Priority="61" Name="Light List Accent 3"/>
  <w:LsdException Locked="false" Priority="62" Name="Light Grid Accent 3"/>
  <w:LsdException Locked="false" Priority="63" Name="Medium Shading 1 Accent 3"/>
  <w:LsdException Locked="false" Priority="64" Name="Medium Shading 2 Accent 3"/>
  <w:LsdException Locked="false" Priority="65" Name="Medium List 1 Accent 3"/>
  <w:LsdException Locked="false" Priority="66" Name="Medium List 2 Accent 3"/>
  <w:LsdException Locked="false" Priority="67" Name="Medium Grid 1 Accent 3"/>
  <w:LsdException Locked="false" Priority="68" Name="Medium Grid 2 Accent 3"/>
  <w:LsdException Locked="false" Priority="69" Name="Medium Grid 3 Accent 3"/>
  <w:LsdException Locked="false" Priority="70" Name="Dark List Accent 3"/>
  <w:LsdException Locked="false" Priority="71" Name="Colorful Shading Accent 3"/>
  <w:LsdException Locked="false" Priority="72" Name="Colorful List Accent 3"/>
  <w:LsdException Locked="false" Priority="73" Name="Colorful Grid Accent 3"/>
  <w:LsdException Locked="false" Priority="60" Name="Light Shading Accent 4"/>
  <w:LsdException Locked="false" Priority="61" Name="Light List Accent 4"/>
  <w:LsdException Locked="false" Priority="62" Name="Light Grid Accent 4"/>
  <w:LsdException Locked="false" Priority="63" Name="Medium Shading 1 Accent 4"/>
  <w:LsdException Locked="false" Priority="64" Name="Medium Shading 2 Accent 4"/>
  <w:LsdException Locked="false" Priority="65" Name="Medium List 1 Accent 4"/>
  <w:LsdException Locked="false" Priority="66" Name="Medium List 2 Accent 4"/>
  <w:LsdException Locked="false" Priority="67" Name="Medium Grid 1 Accent 4"/>
  <w:LsdException Locked="false" Priority="68" Name="Medium Grid 2 Accent 4"/>
  <w:LsdException Locked="false" Priority="69" Name="Medium Grid 3 Accent 4"/>
  <w:LsdException Locked="false" Priority="70" Name="Dark List Accent 4"/>
  <w:LsdException Locked="false" Priority="71" Name="Colorful Shading Accent 4"/>
  <w:LsdException Locked="false" Priority="72" Name="Colorful List Accent 4"/>
  <w:LsdException Locked="false" Priority="73" Name="Colorful Grid Accent 4"/>
  <w:LsdException Locked="false" Priority="60" Name="Light Shading Accent 5"/>
  <w:LsdException Locked="false" Priority="61" Name="Light List Accent 5"/>
  <w:LsdException Locked="false" Priority="62" Name="Light Grid Accent 5"/>
  <w:LsdException Locked="false" Priority="63" Name="Medium Shading 1 Accent 5"/>
  <w:LsdException Locked="false" Priority="64" Name="Medium Shading 2 Accent 5"/>
  <w:LsdException Locked="false" Priority="65" Name="Medium List 1 Accent 5"/>
  <w:LsdException Locked="false" Priority="66" Name="Medium List 2 Accent 5"/>
  <w:LsdException Locked="false" Priority="67" Name="Medium Grid 1 Accent 5"/>
  <w:LsdException Locked="false" Priority="68" Name="Medium Grid 2 Accent 5"/>
  <w:LsdException Locked="false" Priority="69" Name="Medium Grid 3 Accent 5"/>
  <w:LsdException Locked="false" Priority="70" Name="Dark List Accent 5"/>
  <w:LsdException Locked="false" Priority="71" Name="Colorful Shading Accent 5"/>
  <w:LsdException Locked="false" Priority="72" Name="Colorful List Accent 5"/>
  <w:LsdException Locked="false" Priority="73" Name="Colorful Grid Accent 5"/>
  <w:LsdException Locked="false" Priority="60" Name="Light Shading Accent 6"/>
  <w:LsdException Locked="false" Priority="61" Name="Light List Accent 6"/>
  <w:LsdException Locked="false" Priority="62" Name="Light Grid Accent 6"/>
  <w:LsdException Locked="false" Priority="63" Name="Medium Shading 1 Accent 6"/>
  <w:LsdException Locked="false" Priority="64" Name="Medium Shading 2 Accent 6"/>
  <w:LsdException Locked="false" Priority="65" Name="Medium List 1 Accent 6"/>
  <w:LsdException Locked="false" Priority="66" Name="Medium List 2 Accent 6"/>
  <w:LsdException Locked="false" Priority="67" Name="Medium Grid 1 Accent 6"/>
  <w:LsdException Locked="false" Priority="68" Name="Medium Grid 2 Accent 6"/>
  <w:LsdException Locked="false" Priority="69" Name="Medium Grid 3 Accent 6"/>
  <w:LsdException Locked="false" Priority="70" Name="Dark List Accent 6"/>
  <w:LsdException Locked="false" Priority="71" Name="Colorful Shading Accent 6"/>
  <w:LsdException Locked="false" Priority="72" Name="Colorful List Accent 6"/>
  <w:LsdException Locked="false" Priority="73" Name="Colorful Grid Accent 6"/>
  <w:LsdException Locked="false" Priority="19" QFormat="true"
   Name="Subtle Emphasis"/>
  <w:LsdException Locked="false" Priority="21" QFormat="true"
   Name="Intense Emphasis"/>
  <w:LsdException Locked="false" Priority="31" QFormat="true"
   Name="Subtle Reference"/>
  <w:LsdException Locked="false" Priority="32" QFormat="true"
   Name="Intense Reference"/>
  <w:LsdException Locked="false" Priority="33" QFormat="true" Name="Book Title"/>
  <w:LsdException Locked="false" Priority="37" SemiHidden="true"
   UnhideWhenUsed="true" Name="Bibliography"/>
  <w:LsdException Locked="false" Priority="39" SemiHidden="true"
   UnhideWhenUsed="true" QFormat="true" Name="TOC Heading"/>
  <w:LsdException Locked="false" Priority="49" Name="Grid Table 4"/>
  <w:LsdException Locked="false" Priority="50" Name="Grid Table 5 Dark"/>
  <w:LsdException Locked="false" Priority="51" Name="Grid Table 6 Colorful"/>
  <w:LsdException Locked="false" Priority="52" Name="Grid Table 7 Colorful"/>
  <w:LsdException Locked="false" Priority="46"
   Name="Grid Table 1 Light Accent 1"/>
  <w:LsdException Locked="false" Priority="47" Name="Grid Table 2 Accent 1"/>
  <w:LsdException Locked="false" Priority="48" Name="Grid Table 3 Accent 1"/>
  <w:LsdException Locked="false" Priority="49" Name="Grid Table 4 Accent 1"/>
  <w:LsdException Locked="false" Priority="50" Name="Grid Table 5 Dark Accent 1"/>
  <w:LsdException Locked="false" Priority="51"
   Name="Grid Table 6 Colorful Accent 1"/>
  <w:LsdException Locked="false" Priority="52"
   Name="Grid Table 7 Colorful Accent 1"/>
  <w:LsdException Locked="false" Priority="46"
   Name="Grid Table 1 Light Accent 2"/>
  <w:LsdException Locked="false" Priority="47" Name="Grid Table 2 Accent 2"/>
  <w:LsdException Locked="false" Priority="48" Name="Grid Table 3 Accent 2"/>
  <w:LsdException Locked="false" Priority="49" Name="Grid Table 4 Accent 2"/>
  <w:LsdException Locked="false" Priority="50" Name="Grid Table 5 Dark Accent 2"/>
  <w:LsdException Locked="false" Priority="51"
   Name="Grid Table 6 Colorful Accent 2"/>
  <w:LsdException Locked="false" Priority="52"
   Name="Grid Table 7 Colorful Accent 2"/>
  <w:LsdException Locked="false" Priority="46"
   Name="Grid Table 1 Light Accent 3"/>
  <w:LsdException Locked="false" Priority="47" Name="Grid Table 2 Accent 3"/>
  <w:LsdException Locked="false" Priority="48" Name="Grid Table 3 Accent 3"/>
  <w:LsdException Locked="false" Priority="49" Name="Grid Table 4 Accent 3"/>
  <w:LsdException Locked="false" Priority="50" Name="Grid Table 5 Dark Accent 3"/>
  <w:LsdException Locked="false" Priority="51"
   Name="Grid Table 6 Colorful Accent 3"/>
  <w:LsdException Locked="false" Priority="52"
   Name="Grid Table 7 Colorful Accent 3"/>
  <w:LsdException Locked="false" Priority="46"
   Name="Grid Table 1 Light Accent 4"/>
  <w:LsdException Locked="false" Priority="47" Name="Grid Table 2 Accent 4"/>
  <w:LsdException Locked="false" Priority="48" Name="Grid Table 3 Accent 4"/>
  <w:LsdException Locked="false" Priority="49" Name="Grid Table 4 Accent 4"/>
  <w:LsdException Locked="false" Priority="50" Name="Grid Table 5 Dark Accent 4"/>
  <w:LsdException Locked="false" Priority="51"
   Name="Grid Table 6 Colorful Accent 4"/>
  <w:LsdException Locked="false" Priority="52"
   Name="Grid Table 7 Colorful Accent 4"/>
  <w:LsdException Locked="false" Priority="46"
   Name="Grid Table 1 Light Accent 5"/>
  <w:LsdException Locked="false" Priority="47" Name="Grid Table 2 Accent 5"/>
  <w:LsdException Locked="false" Priority="48" Name="Grid Table 3 Accent 5"/>
  <w:LsdException Locked="false" Priority="49" Name="Grid Table 4 Accent 5"/>
  <w:LsdException Locked="false" Priority="50" Name="Grid Table 5 Dark Accent 5"/>
  <w:LsdException Locked="false" Priority="51"
   Name="Grid Table 6 Colorful Accent 5"/>
  <w:LsdException Locked="false" Priority="52"
   Name="Grid Table 7 Colorful Accent 5"/>
  <w:LsdException Locked="false" Priority="46"
   Name="Grid Table 1 Light Accent 6"/>
  <w:LsdException Locked="false" Priority="47" Name="Grid Table 2 Accent 6"/>
  <w:LsdException Locked="false" Priority="48" Name="Grid Table 3 Accent 6"/>
  <w:LsdException Locked="false" Priority="49" Name="Grid Table 4 Accent 6"/>
  <w:LsdException Locked="false" Priority="50" Name="Grid Table 5 Dark Accent 6"/>
  <w:LsdException Locked="false" Priority="51"
   Name="Grid Table 6 Colorful Accent 6"/>
  <w:LsdException Locked="false" Priority="52"
   Name="Grid Table 7 Colorful Accent 6"/>
  <w:LsdException Locked="false" Priority="46" Name="List Table 1 Light"/>
  <w:LsdException Locked="false" Priority="47" Name="List Table 2"/>
  <w:LsdException Locked="false" Priority="48" Name="List Table 3"/>
  <w:LsdException Locked="false" Priority="49" Name="List Table 4"/>
  <w:LsdException Locked="false" Priority="50" Name="List Table 5 Dark"/>
  <w:LsdException Locked="false" Priority="51" Name="List Table 6 Colorful"/>
  <w:LsdException Locked="false" Priority="52" Name="List Table 7 Colorful"/>
  <w:LsdException Locked="false" Priority="46"
   Name="List Table 1 Light Accent 1"/>
  <w:LsdException Locked="false" Priority="47" Name="List Table 2 Accent 1"/>
  <w:LsdException Locked="false" Priority="48" Name="List Table 3 Accent 1"/>
  <w:LsdException Locked="false" Priority="49" Name="List Table 4 Accent 1"/>
  <w:LsdException Locked="false" Priority="50" Name="List Table 5 Dark Accent 1"/>
  <w:LsdException Locked="false" Priority="51"
   Name="List Table 6 Colorful Accent 1"/>
  <w:LsdException Locked="false" Priority="52"
   Name="List Table 7 Colorful Accent 1"/>
  <w:LsdException Locked="false" Priority="46"
   Name="List Table 1 Light Accent 2"/>
  <w:LsdException Locked="false" Priority="47" Name="List Table 2 Accent 2"/>
  <w:LsdException Locked="false" Priority="48" Name="List Table 3 Accent 2"/>
  <w:LsdException Locked="false" Priority="49" Name="List Table 4 Accent 2"/>
  <w:LsdException Locked="false" Priority="50" Name="List Table 5 Dark Accent 2"/>
  <w:LsdException Locked="false" Priority="51"
   Name="List Table 6 Colorful Accent 2"/>
  <w:LsdException Locked="false" Priority="52"
   Name="List Table 7 Colorful Accent 2"/>
  <w:LsdException Locked="false" Priority="46"
   Name="List Table 1 Light Accent 3"/>
  <w:LsdException Locked="false" Priority="47" Name="List Table 2 Accent 3"/>
  <w:LsdException Locked="false" Priority="48" Name="List Table 3 Accent 3"/>
  <w:LsdException Locked="false" Priority="49" Name="List Table 4 Accent 3"/>
  <w:LsdException Locked="false" Priority="50" Name="List Table 5 Dark Accent 3"/>
  <w:LsdException Locked="false" Priority="51"
   Name="List Table 6 Colorful Accent 3"/>
  <w:LsdException Locked="false" Priority="52"
   Name="List Table 7 Colorful Accent 3"/>
  <w:LsdException Locked="false" Priority="46"
   Name="List Table 1 Light Accent 4"/>
  <w:LsdException Locked="false" Priority="47" Name="List Table 2 Accent 4"/>
  <w:LsdException Locked="false" Priority="48" Name="List Table 3 Accent 4"/>
  <w:LsdException Locked="false" Priority="49" Name="List Table 4 Accent 4"/>
  <w:LsdException Locked="false" Priority="50" Name="List Table 5 Dark Accent 4"/>
  <w:LsdException Locked="false" Priority="51"
   Name="List Table 6 Colorful Accent 4"/>
  <w:LsdException Locked="false" Priority="52"
   Name="List Table 7 Colorful Accent 4"/>
  <w:LsdException Locked="false" Priority="46"
   Name="List Table 1 Light Accent 5"/>
  <w:LsdException Locked="false" Priority="47" Name="List Table 2 Accent 5"/>
  <w:LsdException Locked="false" Priority="48" Name="List Table 3 Accent 5"/>
  <w:LsdException Locked="false" Priority="49" Name="List Table 4 Accent 5"/>
  <w:LsdException Locked="false" Priority="50" Name="List Table 5 Dark Accent 5"/>
  <w:LsdException Locked="false" Priority="51"
   Name="List Table 6 Colorful Accent 5"/>
  <w:LsdException Locked="false" Priority="52"
   Name="List Table 7 Colorful Accent 5"/>
  <w:LsdException Locked="false" Priority="46"
   Name="List Table 1 Light Accent 6"/>
  <w:LsdException Locked="false" Priority="47" Name="List Table 2 Accent 6"/>
  <w:LsdException Locked="false" Priority="48" Name="List Table 3 Accent 6"/>
  <w:LsdException Locked="false" Priority="49" Name="List Table 4 Accent 6"/>
  <w:LsdException Locked="false" Priority="50" Name="List Table 5 Dark Accent 6"/>
  <w:LsdException Locked="false" Priority="51"
   Name="List Table 6 Colorful Accent 6"/>
  <w:LsdException Locked="false" Priority="52"
   Name="List Table 7 Colorful Accent 6"/>
  <w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true"
   Name="Mention"/>
  <w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true"
   Name="Smart Hyperlink"/>
  <w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true"
   Name="Hashtag"/>
  <w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true"
   Name="Unresolved Mention"/>
 </w:LatentStyles>
</xml><![endif]-->
<style>
<!--
 /* Font Definitions */
 @font-face
	{font-family:Wingdings;
	panose-1:5 0 0 0 0 0 0 0 0 0;
	mso-font-charset:2;
	mso-generic-font-family:decorative;
	mso-font-pitch:variable;
	mso-font-signature:0 268435456 0 0 -2147483648 0;}
@font-face
	{font-family:"Cambria Math";
	panose-1:2 4 5 3 5 4 6 3 2 4;
	mso-font-charset:0;
	mso-generic-font-family:roman;
	mso-font-pitch:variable;
	mso-font-signature:3 0 0 0 1 0;}
@font-face
	{font-family:Times;
	panose-1:0 0 5 0 0 0 0 2 0 0;
	mso-font-charset:0;
	mso-generic-font-family:auto;
	mso-font-pitch:variable;
	mso-font-signature:-536870145 1342185562 0 0 415 0;}
@font-face
	{font-family:"Lucida Grande";
	panose-1:2 11 6 0 4 5 2 2 2 4;
	mso-font-charset:0;
	mso-generic-font-family:swiss;
	mso-font-pitch:variable;
	mso-font-signature:-520090897 1342218751 0 0 447 0;}
 /* Style Definitions */
 p.MsoNormal, li.MsoNormal, div.MsoNormal
	{mso-style-unhide:no;
	mso-style-qformat:yes;
	mso-style-parent:"";
	margin:0in;
	margin-bottom:.0001pt;
	mso-pagination:widow-orphan;
	font-size:12.0pt;
	font-family:"Times New Roman",serif;
	mso-fareast-font-family:"Times New Roman";}
p.MsoHeader, li.MsoHeader, div.MsoHeader
	{mso-style-priority:99;
	mso-style-link:"Header Char";
	margin:0in;
	margin-bottom:.0001pt;
	mso-pagination:widow-orphan;
	tab-stops:center 3.25in right 6.5in;
	font-size:12.0pt;
	font-family:"Times New Roman",serif;
	mso-fareast-font-family:"Times New Roman";}
p.MsoFooter, li.MsoFooter, div.MsoFooter
	{mso-style-priority:99;
	mso-style-link:"Footer Char";
	margin:0in;
	margin-bottom:.0001pt;
	mso-pagination:widow-orphan;
	tab-stops:center 3.25in right 6.5in;
	font-size:12.0pt;
	font-family:"Times New Roman",serif;
	mso-fareast-font-family:"Times New Roman";}
span.MsoPageNumber
	{mso-style-priority:99;
	mso-ansi-font-size:10.0pt;
	font-family:Times;
	mso-ascii-font-family:Times;
	mso-hansi-font-family:Times;}
a:link, span.MsoHyperlink
	{mso-style-priority:99;
	color:#0563C1;
	mso-themecolor:hyperlink;
	text-decoration:underline;
	text-underline:single;}
a:visited, span.MsoHyperlinkFollowed
	{mso-style-noshow:yes;
	mso-style-priority:99;
	color:#954F72;
	mso-themecolor:followedhyperlink;
	text-decoration:underline;
	text-underline:single;}
p.MsoAcetate, li.MsoAcetate, div.MsoAcetate
	{mso-style-noshow:yes;
	mso-style-priority:99;
	mso-style-link:"Balloon Text Char";
	margin:0in;
	margin-bottom:.0001pt;
	mso-pagination:widow-orphan;
	font-size:9.0pt;
	font-family:"Lucida Grande",sans-serif;
	mso-fareast-font-family:"Times New Roman";}
p.MsoListParagraph, li.MsoListParagraph, div.MsoListParagraph
	{mso-style-priority:34;
	mso-style-unhide:no;
	mso-style-qformat:yes;
	margin-top:0in;
	margin-right:0in;
	margin-bottom:0in;
	margin-left:.5in;
	margin-bottom:.0001pt;
	mso-add-space:auto;
	mso-pagination:widow-orphan;
	font-size:12.0pt;
	font-family:"Times New Roman",serif;
	mso-fareast-font-family:"Times New Roman";}
p.MsoListParagraphCxSpFirst, li.MsoListParagraphCxSpFirst, div.MsoListParagraphCxSpFirst
	{mso-style-priority:34;
	mso-style-unhide:no;
	mso-style-qformat:yes;
	mso-style-type:export-only;
	margin-top:0in;
	margin-right:0in;
	margin-bottom:0in;
	margin-left:.5in;
	margin-bottom:.0001pt;
	mso-add-space:auto;
	mso-pagination:widow-orphan;
	font-size:12.0pt;
	font-family:"Times New Roman",serif;
	mso-fareast-font-family:"Times New Roman";}
p.MsoListParagraphCxSpMiddle, li.MsoListParagraphCxSpMiddle, div.MsoListParagraphCxSpMiddle
	{mso-style-priority:34;
	mso-style-unhide:no;
	mso-style-qformat:yes;
	mso-style-type:export-only;
	margin-top:0in;
	margin-right:0in;
	margin-bottom:0in;
	margin-left:.5in;
	margin-bottom:.0001pt;
	mso-add-space:auto;
	mso-pagination:widow-orphan;
	font-size:12.0pt;
	font-family:"Times New Roman",serif;
	mso-fareast-font-family:"Times New Roman";}
p.MsoListParagraphCxSpLast, li.MsoListParagraphCxSpLast, div.MsoListParagraphCxSpLast
	{mso-style-priority:34;
	mso-style-unhide:no;
	mso-style-qformat:yes;
	mso-style-type:export-only;
	margin-top:0in;
	margin-right:0in;
	margin-bottom:0in;
	margin-left:.5in;
	margin-bottom:.0001pt;
	mso-add-space:auto;
	mso-pagination:widow-orphan;
	font-size:12.0pt;
	font-family:"Times New Roman",serif;
	mso-fareast-font-family:"Times New Roman";}
span.UnresolvedMention1
	{mso-style-name:"Unresolved Mention1";
	mso-style-noshow:yes;
	mso-style-priority:99;
	color:#605E5C;
	background:#E1DFDD;}
span.BalloonTextChar
	{mso-style-name:"Balloon Text Char";
	mso-style-noshow:yes;
	mso-style-priority:99;
	mso-style-unhide:no;
	mso-style-locked:yes;
	mso-style-link:"Balloon Text";
	mso-ansi-font-size:9.0pt;
	mso-bidi-font-size:9.0pt;
	font-family:"Lucida Grande",sans-serif;
	mso-ascii-font-family:"Lucida Grande";
	mso-hansi-font-family:"Lucida Grande";
	mso-bidi-font-family:"Lucida Grande";}
span.UnresolvedMention2
	{mso-style-name:"Unresolved Mention2";
	mso-style-noshow:yes;
	mso-style-priority:99;
	color:#605E5C;
	background:#E1DFDD;}
span.HeaderChar
	{mso-style-name:"Header Char";
	mso-style-priority:99;
	mso-style-unhide:no;
	mso-style-locked:yes;
	mso-style-link:Header;}
span.FooterChar
	{mso-style-name:"Footer Char";
	mso-style-priority:99;
	mso-style-unhide:no;
	mso-style-locked:yes;
	mso-style-link:Footer;}
span.SpellE
	{mso-style-name:"";
	mso-spl-e:yes;}
span.GramE
	{mso-style-name:"";
	mso-gram-e:yes;}
.MsoChpDefault
	{mso-style-type:export-only;
	mso-default-props:yes;
	font-family:"Calibri",sans-serif;
	mso-ascii-font-family:Calibri;
	mso-ascii-theme-font:minor-latin;
	mso-fareast-font-family:Calibri;
	mso-fareast-theme-font:minor-latin;
	mso-hansi-font-family:Calibri;
	mso-hansi-theme-font:minor-latin;
	mso-bidi-font-family:"Times New Roman";
	mso-bidi-theme-font:minor-bidi;}
 /* Page Definitions */
 @page
	{mso-footnote-separator:url("PBYI%208E.fld/header.html") fs;
	mso-footnote-continuation-separator:url("PBYI%208E.fld/header.html") fcs;
	mso-endnote-separator:url("PBYI%208E.fld/header.html") es;
	mso-endnote-continuation-separator:url("PBYI%208E.fld/header.html") ecs;}
@page WordSection1
	{size:8.5in 11.0in;
	margin:1.0in 1.0in 1.0in 1.0in;
	mso-header-margin:.5in;
	mso-footer-margin:.5in;
	mso-even-footer:url("PBYI%208E.fld/header.html") ef1;
	mso-footer:url("PBYI%208E.fld/header.html") f1;
	mso-paper-source:0;}
div.WordSection1
	{page:WordSection1;}
 /* List Definitions */
 @list l0
	{mso-list-id:921137028;
	mso-list-type:hybrid;
	mso-list-template-ids:-1285637366 67698689 67698691 67698693 67698689 67698691 67698693 67698689 67698691 67698693;}
@list l0:level1
	{mso-level-number-format:bullet;
	mso-level-text:;
	mso-level-tab-stop:none;
	mso-level-number-position:left;
	text-indent:-.25in;
	font-family:Symbol;}
@list l0:level2
	{mso-level-number-format:bullet;
	mso-level-text:o;
	mso-level-tab-stop:none;
	mso-level-number-position:left;
	text-indent:-.25in;
	font-family:"Courier New";}
@list l0:level3
	{mso-level-number-format:bullet;
	mso-level-text:;
	mso-level-tab-stop:none;
	mso-level-number-position:left;
	text-indent:-.25in;
	font-family:Wingdings;}
@list l0:level4
	{mso-level-number-format:bullet;
	mso-level-text:;
	mso-level-tab-stop:none;
	mso-level-number-position:left;
	text-indent:-.25in;
	font-family:Symbol;}
@list l0:level5
	{mso-level-number-format:bullet;
	mso-level-text:o;
	mso-level-tab-stop:none;
	mso-level-number-position:left;
	text-indent:-.25in;
	font-family:"Courier New";}
@list l0:level6
	{mso-level-number-format:bullet;
	mso-level-text:;
	mso-level-tab-stop:none;
	mso-level-number-position:left;
	text-indent:-.25in;
	font-family:Wingdings;}
@list l0:level7
	{mso-level-number-format:bullet;
	mso-level-text:;
	mso-level-tab-stop:none;
	mso-level-number-position:left;
	text-indent:-.25in;
	font-family:Symbol;}
@list l0:level8
	{mso-level-number-format:bullet;
	mso-level-text:o;
	mso-level-tab-stop:none;
	mso-level-number-position:left;
	text-indent:-.25in;
	font-family:"Courier New";}
@list l0:level9
	{mso-level-number-format:bullet;
	mso-level-text:;
	mso-level-tab-stop:none;
	mso-level-number-position:left;
	text-indent:-.25in;
	font-family:Wingdings;}
ol
	{margin-bottom:0in;}
ul
	{margin-bottom:0in;}
-->
</style>
<!--[if gte mso 10]>
<style>
 /* Style Definitions */
 table.MsoNormalTable
	{mso-style-name:"Table Normal";
	mso-tstyle-rowband-size:0;
	mso-tstyle-colband-size:0;
	mso-style-noshow:yes;
	mso-style-priority:99;
	mso-style-parent:"";
	mso-padding-alt:0in 5.4pt 0in 5.4pt;
	mso-para-margin:0in;
	mso-para-margin-bottom:.0001pt;
	mso-pagination:widow-orphan;
	font-size:12.0pt;
	font-family:"Calibri",sans-serif;
	mso-ascii-font-family:Calibri;
	mso-ascii-theme-font:minor-latin;
	mso-hansi-font-family:Calibri;
	mso-hansi-theme-font:minor-latin;
	mso-bidi-font-family:"Times New Roman";
	mso-bidi-theme-font:minor-bidi;}
</style>
<![endif]--><!--[if gte mso 9]><xml>
 <o:shapedefaults v:ext="edit" spidmax="1026"/>
</xml><![endif]--><!--[if gte mso 9]><xml>
 <o:shapelayout v:ext="edit">
  <o:idmap v:ext="edit" data="1"/>
 </o:shapelayout></xml><![endif]-->
</head>

<body lang=EN-US link="#0563C1" vlink="#954F72" style='tab-interval:.5in'>

<div class=WordSection1>

<p class=MsoNormal align=center style='text-align:center;tab-stops:276.2pt'><b
style='mso-bidi-font-weight:normal'><span style='font-size:18.0pt;font-family:
Times'>Elle Investments Research Report: PBYI<o:p></o:p></span></b></p>

<p class=MsoNormal style='tab-stops:276.2pt'><b style='mso-bidi-font-weight:
normal'><span style='font-size:18.0pt;font-family:Times'><o:p>&nbsp;</o:p></span></b></p>

<p class=MsoNormal style='tab-stops:276.2pt'><span style='font-family:Times'><o:p>&nbsp;</o:p></span></p>

<p class=MsoNormal style='tab-stops:276.2pt'><span style='font-family:Times'>Company:
Puma Biotechnology, Inc.<o:p></o:p></span></p>

<p class=MsoNormal style='tab-stops:276.2pt'><span style='font-family:Times'>Symbol:
<b style='mso-bidi-font-weight:normal'>PBYI<o:p></o:p></b></span></p>

<p class=MsoNormal style='tab-stops:276.2pt'><span style='font-family:Times'>Analysis
Date: 5/22/19<o:p></o:p></span></p>

<p class=MsoNormal style='tab-stops:276.2pt'><span style='font-family:Times'>Analysis
Price: $15.60<o:p></o:p></span></p>

<p class=MsoNormal style='tab-stops:276.2pt'><span style='font-family:Times'>Price
Target (PT): <b style='mso-bidi-font-weight:normal'>$26.27</b><o:p></o:p></span></p>

<p class=MsoNormal style='tab-stops:276.2pt'><span style='font-family:Times'>Upside:
68%<o:p></o:p></span></p>

<p class=MsoNormal style='tab-stops:276.2pt'><span style='font-family:Times'>Dividend:
NA<o:p></o:p></span></p>

<p class=MsoNormal style='tab-stops:276.2pt'><span style='font-family:Times'>Recommendation:
<b style='mso-bidi-font-weight:normal'>Buy<o:p></o:p></b></span></p>

<p class=MsoNormal style='tab-stops:276.2pt'><b style='mso-bidi-font-weight:
normal'><span style='font-family:Times'><o:p>&nbsp;</o:p></span></b></p>

<p class=MsoNormal style='tab-stops:276.2pt'><b style='mso-bidi-font-weight:
normal'><span style='font-family:Times'><o:p>&nbsp;</o:p></span></b></p>

<p class=MsoNormal align=center style='text-align:center;tab-stops:276.2pt'><b
style='mso-bidi-font-weight:normal'><span style='font-size:14.0pt;font-family:
Times'>PBYI: 1-Year Stock Chart<o:p></o:p></span></b></p>

<p class=MsoNormal align=center style='text-align:center;tab-stops:276.2pt'><b
style='mso-bidi-font-weight:normal'><span style='font-size:14.0pt;font-family:
Times'><o:p>&nbsp;</o:p></span></b></p>

<p class=MsoNormal align=center style='text-align:center;tab-stops:276.2pt'><span
style='font-family:Times;mso-no-proof:yes'><!--[if gte vml 1]><v:shapetype
 id="_x0000_t75" coordsize="21600,21600" o:spt="75" o:preferrelative="t"
 path="m@4@5l@4@11@9@11@9@5xe" filled="f" stroked="f">
 <v:stroke joinstyle="miter"/>
 <v:formulas>
  <v:f eqn="if lineDrawn pixelLineWidth 0"/>
  <v:f eqn="sum @0 1 0"/>
  <v:f eqn="sum 0 0 @1"/>
  <v:f eqn="prod @2 1 2"/>
  <v:f eqn="prod @3 21600 pixelWidth"/>
  <v:f eqn="prod @3 21600 pixelHeight"/>
  <v:f eqn="sum @0 0 1"/>
  <v:f eqn="prod @6 1 2"/>
  <v:f eqn="prod @7 21600 pixelWidth"/>
  <v:f eqn="sum @8 21600 0"/>
  <v:f eqn="prod @7 21600 pixelHeight"/>
  <v:f eqn="sum @10 21600 0"/>
 </v:formulas>
 <v:path o:extrusionok="f" gradientshapeok="t" o:connecttype="rect"/>
 <o:lock v:ext="edit" aspectratio="t"/>
</v:shapetype><v:shape id="Picture_x0020_4" o:spid="_x0000_i1036" type="#_x0000_t75"
 style='width:468pt;height:95pt;visibility:visible;mso-wrap-style:square'>
 <v:imagedata src="PBYI%208E.fld/image001.png" o:title=""/>
</v:shape><![endif]--><![if !vml]><img width=468 height=95
src="PBYI%208E.fld/image001.png" v:shapes="Picture_x0020_4"><![endif]></span><span
style='font-family:Times'><o:p></o:p></span></p>

<p class=MsoNormal align=center style='text-align:center;tab-stops:276.2pt'><span
style='font-size:10.0pt;font-family:Times'>Source: Seeking Alpha<o:p></o:p></span></p>

<p class=MsoNormal style='tab-stops:276.2pt'><span style='font-family:Times'><o:p>&nbsp;</o:p></span></p>

<p class=MsoNormal style='tab-stops:276.2pt'><span style='font-family:Times'><o:p>&nbsp;</o:p></span></p>

<p class=MsoNormal style='tab-stops:276.2pt'><b style='mso-bidi-font-weight:
normal'><span style='font-family:Times'>INVESTMENT THESIS:</span></b><span
style='font-family:Times'> <o:p></o:p></span></p>

<p class=MsoNormal style='tab-stops:276.2pt'><span style='font-family:Times'><o:p>&nbsp;</o:p></span></p>

<p class=MsoNormal style='tab-stops:276.2pt'><span style='font-family:Times'>After
seeing strong <span class=SpellE>Nerlynx</span> US sales growth during 4Q18, PBYI
dropped about 30% on 1Q19 results. Due primarily to the large number of
discontinuations, <span class=SpellE>Nerlynx</span> net sales came in at only
$46M, representing a decline of 25% sequentially (with the number of bottles
sold declining 20% sequentially). <o:p></o:p></span></p>

<p class=MsoNormal style='tab-stops:276.2pt'><span style='font-family:Times'><o:p>&nbsp;</o:p></span></p>

<p class=MsoNormal style='tab-stops:276.2pt'><span style='font-family:Times'>Severe
diarrhea was a known side effect during the clinical trials. Management’s
market research indicates that while most physicians are co-prescribing an anti-diarrheal,
many patients are not even filling their prescription (high rates of
non-compliance were also seen during the clinical trials). While continuing to
emphasize the need for both prescribing and taking an anti-diarrheal continues
to be a priority, the high rate of discontinuations (and management’s lowered
2019 net sales guidance) brings previous peak sales estimates of $1B+ into
question.<o:p></o:p></span></p>

<p class=MsoNormal style='tab-stops:276.2pt'><span style='font-family:Times'><o:p>&nbsp;</o:p></span></p>

<p class=MsoNormal style='tab-stops:276.2pt'><span style='font-family:Times'>However,
given the large sell-off post-1Q19 results, even with much lower peak sales
estimates in the $500M+ range, there is still a lot of upside from the current
price.<o:p></o:p></span></p>

<p class=MsoNormal style='tab-stops:276.2pt'><span style='font-family:Times'><o:p>&nbsp;</o:p></span></p>

<p class=MsoNormal style='tab-stops:276.2pt'><span style='font-family:Times'><o:p>&nbsp;</o:p></span></p>

<p class=MsoNormal style='tab-stops:276.2pt'><span style='font-family:Times'><o:p>&nbsp;</o:p></span></p>

<p class=MsoNormal style='tab-stops:276.2pt'><span style='font-family:Times'><o:p>&nbsp;</o:p></span></p>

<p class=MsoNormal align=center style='text-align:center;tab-stops:276.2pt'><b
style='mso-bidi-font-weight:normal'><span style='font-size:14.0pt;font-family:
Times'>PBYI: <span class=SpellE>Nerlynx</span> Quarterly US Net Revenues, 3Q17
– 1Q19</span></b><span style='font-family:Times'><o:p></o:p></span></p>

<p class=MsoNormal style='tab-stops:276.2pt'><span style='font-family:Times'><o:p>&nbsp;</o:p></span></p>

<p class=MsoNormal align=center style='text-align:center;tab-stops:276.2pt'><span
style='font-family:Times;color:red;mso-no-proof:yes'><!--[if gte vml 1]><v:shape
 id="Picture_x0020_5" o:spid="_x0000_i1035" type="#_x0000_t75" style='width:468pt;
 height:352pt;visibility:visible;mso-wrap-style:square'>
 <v:imagedata src="PBYI%208E.fld/image002.png" o:title=""/>
</v:shape><![endif]--><![if !vml]><img width=468 height=352
src="PBYI%208E.fld/image002.png" v:shapes="Picture_x0020_5"><![endif]></span><span
style='font-family:Times;color:red'><o:p></o:p></span></p>

<p class=MsoNormal align=center style='text-align:center;tab-stops:276.2pt'><span
style='font-size:10.0pt;font-family:Times'>Source: PBYI 1Q19 earnings slides<o:p></o:p></span></p>

<p class=MsoNormal style='tab-stops:276.2pt'><span style='font-family:Times;
color:red'><o:p>&nbsp;</o:p></span></p>

<p class=MsoNormal style='tab-stops:276.2pt'><b style='mso-bidi-font-weight:
normal'><span style='font-family:Times'><o:p>&nbsp;</o:p></span></b></p>

<p class=MsoNormal style='tab-stops:276.2pt'><b style='mso-bidi-font-weight:
normal'><span style='font-family:Times'>LIQUIDITY POSITION:</span></b><span
style='font-family:Times'> Good<o:p></o:p></span></p>

<p class=MsoNormal style='tab-stops:276.2pt'><span style='font-family:Times'><o:p>&nbsp;</o:p></span></p>

<p class=MsoNormal style='tab-stops:276.2pt'><span style='font-family:Times'>As
of March 31, 2019, PBYI had $150M in cash, cash equivalents, and marketable
securities. Adding in the $60M they received upfront from Pierre Fabre in early
April brings total cash to $210M. Given the new lower 2019 net sales guidance
of $230M, the quarterly cash burn will be about $35M for the remainder of the
year (not including any license revenues or potential regulatory or commercial
milestones). While the lower sales guidance has changed the cash runway a bit,
we still see the risk of dilution as being somewhat low.<o:p></o:p></span></p>

<p class=MsoNormal style='tab-stops:276.2pt'><span style='font-family:Times'><o:p>&nbsp;</o:p></span></p>

<p class=MsoNormal style='tab-stops:276.2pt'><b style='mso-bidi-font-weight:
normal'><span style='font-family:Times'><o:p>&nbsp;</o:p></span></b></p>

<p class=MsoNormal style='tab-stops:276.2pt'><b style='mso-bidi-font-weight:
normal'><span style='font-family:Times'><o:p>&nbsp;</o:p></span></b></p>

<p class=MsoNormal style='tab-stops:276.2pt'><b style='mso-bidi-font-weight:
normal'><span style='font-family:Times'><o:p>&nbsp;</o:p></span></b></p>

<p class=MsoNormal style='tab-stops:276.2pt'><b style='mso-bidi-font-weight:
normal'><span style='font-family:Times'><o:p>&nbsp;</o:p></span></b></p>

<p class=MsoNormal style='tab-stops:276.2pt'><b style='mso-bidi-font-weight:
normal'><span style='font-family:Times'><o:p>&nbsp;</o:p></span></b></p>

<p class=MsoNormal style='tab-stops:276.2pt'><b style='mso-bidi-font-weight:
normal'><span style='font-family:Times'><o:p>&nbsp;</o:p></span></b></p>

<p class=MsoNormal style='tab-stops:276.2pt'><b style='mso-bidi-font-weight:
normal'><span style='font-family:Times'><o:p>&nbsp;</o:p></span></b></p>

<p class=MsoNormal style='tab-stops:276.2pt'><b style='mso-bidi-font-weight:
normal'><span style='font-family:Times'>COMMERCIAL PROSPECTS:</span></b><span
style='font-family:Times'> Good<o:p></o:p></span></p>

<p class=MsoNormal style='tab-stops:276.2pt'><span style='font-family:Times'><o:p>&nbsp;</o:p></span></p>

<p class=MsoNormal align=center style='text-align:center;tab-stops:276.2pt'><b
style='mso-bidi-font-weight:normal'><span style='font-size:14.0pt;font-family:
Times'>PBYI: Drug Development Pipeline</span></b><span style='font-family:Times'><o:p></o:p></span></p>

<p class=MsoNormal style='tab-stops:276.2pt'><span style='font-family:Times'><o:p>&nbsp;</o:p></span></p>

<p class=MsoNormal align=center style='text-align:center;tab-stops:276.2pt'><span
style='font-family:Times;mso-no-proof:yes'><!--[if gte vml 1]><v:shape id="Picture_x0020_1"
 o:spid="_x0000_i1034" type="#_x0000_t75" style='width:468pt;height:352pt;
 visibility:visible;mso-wrap-style:square'>
 <v:imagedata src="PBYI%208E.fld/image003.png" o:title=""/>
</v:shape><![endif]--><![if !vml]><img width=468 height=352
src="PBYI%208E.fld/image003.png" v:shapes="Picture_x0020_1"><![endif]></span><span
style='font-family:Times'><o:p></o:p></span></p>

<p class=MsoNormal align=center style='text-align:center;tab-stops:276.2pt'><span
style='font-size:10.0pt;font-family:Times'>Source: PBYI website<o:p></o:p></span></p>

<p class=MsoNormal style='tab-stops:276.2pt'><span style='font-family:Times'><o:p>&nbsp;</o:p></span></p>

<p class=MsoNormal style='tab-stops:276.2pt'><span style='font-family:Times'><o:p>&nbsp;</o:p></span></p>

<p class=MsoNormal style='tab-stops:276.2pt'><span style='font-family:Times'>At
the moment, <span class=SpellE>Nerlynx</span> is approved as an extended
adjuvant monotherapy for HER2+ breast cancer (post-Herceptin). Given the large
number of discontinuations that we saw from the 1Q19 results, previous peak
sales estimates for <span class=SpellE>Nerlynx</span> need to be revised
downwards. Below you can see our calculations for the addressable market size
in the US and EU for this currently-approved indication, as well as the
addressable market size for both third- and fourth-line HER2+ metastatic breast
cancer (MBC) treatment in the US. <o:p></o:p></span></p>

<p class=MsoNormal style='tab-stops:276.2pt'><span style='font-family:Times'><o:p>&nbsp;</o:p></span></p>

<p class=MsoNormal align=center style='text-align:center;tab-stops:276.2pt'><b
style='mso-bidi-font-weight:normal'><span style='font-size:14.0pt;font-family:
Times'><o:p>&nbsp;</o:p></span></b></p>

<p class=MsoNormal align=center style='text-align:center;tab-stops:276.2pt'><b
style='mso-bidi-font-weight:normal'><span style='font-size:14.0pt;font-family:
Times'><o:p>&nbsp;</o:p></span></b></p>

<p class=MsoNormal align=center style='text-align:center;tab-stops:276.2pt'><b
style='mso-bidi-font-weight:normal'><span style='font-size:14.0pt;font-family:
Times'><o:p>&nbsp;</o:p></span></b></p>

<p class=MsoNormal align=center style='text-align:center;tab-stops:276.2pt'><b
style='mso-bidi-font-weight:normal'><span style='font-size:14.0pt;font-family:
Times'><o:p>&nbsp;</o:p></span></b></p>

<p class=MsoNormal align=center style='text-align:center;tab-stops:276.2pt'><b
style='mso-bidi-font-weight:normal'><span style='font-size:14.0pt;font-family:
Times'><o:p>&nbsp;</o:p></span></b></p>

<p class=MsoNormal align=center style='text-align:center;tab-stops:276.2pt'><b
style='mso-bidi-font-weight:normal'><span style='font-size:14.0pt;font-family:
Times'><o:p>&nbsp;</o:p></span></b></p>

<p class=MsoNormal align=center style='text-align:center;tab-stops:276.2pt'><b
style='mso-bidi-font-weight:normal'><span style='font-size:14.0pt;font-family:
Times'>PBYI: US/EU HER2+ Post-Herceptin Early-Stage Breast Cancer Market Size<o:p></o:p></span></b></p>

<p class=MsoNormal align=center style='text-align:center;tab-stops:276.2pt'><b
style='mso-bidi-font-weight:normal'><span style='font-size:14.0pt;font-family:
Times'><o:p>&nbsp;</o:p></span></b></p>

<p class=MsoNormal align=center style='text-align:center;tab-stops:276.2pt'><span
style='font-family:Times;mso-no-proof:yes'><!--[if gte vml 1]><v:shape id="_x0000_i1033"
 type="#_x0000_t75" alt="" style='width:423pt;height:3in;mso-width-percent:0;
 mso-height-percent:0;mso-width-percent:0;mso-height-percent:0' o:ole="">
 <v:imagedata src="PBYI%208E.fld/image004.emz" o:title=""/>
</v:shape><![endif]--><![if !vml]><img width=423 height=216
src="PBYI%208E.fld/image005.png" v:shapes="_x0000_i1033"><![endif]><!--[if gte mso 9]><xml>
 <o:OLEObject Type="Embed" ProgID="Excel.Sheet.12" ShapeID="_x0000_i1033"
  DrawAspect="Content" ObjectID="_1620805635">
 </o:OLEObject>
</xml><![endif]--></span><span style='font-family:Times'><o:p></o:p></span></p>

<p class=MsoNormal style='tab-stops:276.2pt'><span style='font-family:Times'><o:p>&nbsp;</o:p></span></p>

<p class=MsoNormal style='tab-stops:276.2pt'><b style='mso-bidi-font-weight:
normal'><span style='font-size:14.0pt;font-family:Times'><o:p>&nbsp;</o:p></span></b></p>

<p class=MsoNormal align=center style='text-align:center;tab-stops:276.2pt'><b
style='mso-bidi-font-weight:normal'><span style='font-size:14.0pt;font-family:
Times'>PBYI: US Third-Line HER2+ MBC Market Size<o:p></o:p></span></b></p>

<p class=MsoNormal align=center style='text-align:center;tab-stops:276.2pt'><b
style='mso-bidi-font-weight:normal'><span style='font-size:14.0pt;font-family:
Times'><o:p>&nbsp;</o:p></span></b></p>

<p class=MsoNormal align=center style='text-align:center;tab-stops:276.2pt'><b
style='mso-bidi-font-weight:normal'><span style='font-size:14.0pt;font-family:
Times;mso-no-proof:yes'><!--[if gte vml 1]><v:shape id="_x0000_i1032" type="#_x0000_t75"
 alt="" style='width:423pt;height:73pt;mso-width-percent:0;
 mso-height-percent:0;mso-width-percent:0;mso-height-percent:0' o:ole="">
 <v:imagedata src="PBYI%208E.fld/image006.emz" o:title=""/>
</v:shape><![endif]--><![if !vml]><img width=423 height=73
src="PBYI%208E.fld/image007.png" v:shapes="_x0000_i1032"><![endif]><!--[if gte mso 9]><xml>
 <o:OLEObject Type="Embed" ProgID="Excel.Sheet.12" ShapeID="_x0000_i1032"
  DrawAspect="Content" ObjectID="_1620805636">
 </o:OLEObject>
</xml><![endif]--></span></b><b style='mso-bidi-font-weight:normal'><span
style='font-size:14.0pt;font-family:Times'><o:p></o:p></span></b></p>

<p class=MsoNormal align=center style='text-align:center;tab-stops:276.2pt'><b
style='mso-bidi-font-weight:normal'><span style='font-size:14.0pt;font-family:
Times'><o:p>&nbsp;</o:p></span></b></p>

<p class=MsoNormal align=center style='text-align:center;tab-stops:276.2pt'><b
style='mso-bidi-font-weight:normal'><span style='font-size:14.0pt;font-family:
Times'><o:p>&nbsp;</o:p></span></b></p>

<p class=MsoNormal align=center style='text-align:center;tab-stops:276.2pt'><b
style='mso-bidi-font-weight:normal'><span style='font-size:14.0pt;font-family:
Times'>PBYI: US Fourth-Line HER2+ MBC Market Size<o:p></o:p></span></b></p>

<p class=MsoNormal align=center style='text-align:center;tab-stops:276.2pt'><b
style='mso-bidi-font-weight:normal'><span style='font-size:14.0pt;font-family:
Times'><o:p>&nbsp;</o:p></span></b></p>

<p class=MsoNormal align=center style='text-align:center;tab-stops:276.2pt'><b
style='mso-bidi-font-weight:normal'><span style='font-size:14.0pt;font-family:
Times;mso-no-proof:yes'><!--[if gte vml 1]><v:shape id="_x0000_i1031" type="#_x0000_t75"
 alt="" style='width:423pt;height:73pt;mso-width-percent:0;
 mso-height-percent:0;mso-width-percent:0;mso-height-percent:0' o:ole="">
 <v:imagedata src="PBYI%208E.fld/image008.emz" o:title=""/>
</v:shape><![endif]--><![if !vml]><img width=423 height=73
src="PBYI%208E.fld/image009.png" v:shapes="_x0000_i1031"><![endif]><!--[if gte mso 9]><xml>
 <o:OLEObject Type="Embed" ProgID="Excel.Sheet.12" ShapeID="_x0000_i1031"
  DrawAspect="Content" ObjectID="_1620805637">
 </o:OLEObject>
</xml><![endif]--></span></b><b style='mso-bidi-font-weight:normal'><span
style='font-size:14.0pt;font-family:Times'><o:p></o:p></span></b></p>

<p class=MsoNormal align=center style='text-align:center;tab-stops:276.2pt'><span
style='font-size:10.0pt;font-family:Times'>Sources: Elle Investments, 1) Bank
of America Merrill Lynch Health Care Conference slides (May 5, 2019), 2) </span><a
href="https://www.goodrx.com/nerlynx"><span class=SpellE><span
style='font-size:10.0pt;font-family:Times'>GoodRx</span></span></a><span
style='font-size:10.0pt;font-family:Times'>, 3) </span><a
href="https://www.fiercepharma.com/financials/puma-s-breast-cancer-drug-nerlynx-to-command-10k-a-month-despite-concerns-report"><span
class=SpellE><span style='font-size:10.0pt;font-family:Times'>FiercePharma</span></span></a><span
style='font-family:Times'><o:p></o:p></span></p>

<p class=MsoNormal style='tab-stops:276.2pt'><span style='font-family:Times'><o:p>&nbsp;</o:p></span></p>

<p class=MsoNormal style='tab-stops:276.2pt'><span style='font-family:Times'><o:p>&nbsp;</o:p></span></p>

<p class=MsoNormal style='tab-stops:276.2pt'><span style='font-family:Times'>We
then make some reasonable assumptions to compute our PT for PBYI:<o:p></o:p></span></p>

<p class=MsoNormal style='tab-stops:276.2pt'><span style='font-family:Times'><o:p>&nbsp;</o:p></span></p>

<p class=MsoListParagraphCxSpFirst style='text-indent:-.25in;mso-list:l0 level1 lfo1;
tab-stops:276.2pt'><![if !supportLists]><span style='font-family:Symbol;
mso-fareast-font-family:Symbol;mso-bidi-font-family:Symbol'><span
style='mso-list:Ignore'>·<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><![endif]><span style='font-family:Times'>A midpoint
market share of 15%<o:p></o:p></span></p>

<p class=MsoListParagraphCxSpMiddle style='text-indent:-.25in;mso-list:l0 level1 lfo1;
tab-stops:276.2pt'><![if !supportLists]><span style='font-family:Symbol;
mso-fareast-font-family:Symbol;mso-bidi-font-family:Symbol'><span
style='mso-list:Ignore'>·<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><![endif]><span style='font-family:Times'>A gross-to-net
reduction of 13% (updated 2019 guidance)<o:p></o:p></span></p>

<p class=MsoListParagraphCxSpMiddle style='text-indent:-.25in;mso-list:l0 level1 lfo1;
tab-stops:276.2pt'><![if !supportLists]><span style='font-family:Symbol;
mso-fareast-font-family:Symbol;mso-bidi-font-family:Symbol'><span
style='mso-list:Ignore'>·<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><![endif]><span style='font-family:Times'>A 14% royalty on
global net sales to be paid to Pfizer (amended agreement calls for a fixed rate
from low-to-mid teens)<o:p></o:p></span></p>

<p class=MsoListParagraphCxSpMiddle style='text-indent:-.25in;mso-list:l0 level1 lfo1;
tab-stops:276.2pt'><![if !supportLists]><span style='font-family:Symbol;
mso-fareast-font-family:Symbol;mso-bidi-font-family:Symbol'><span
style='mso-list:Ignore'>·<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><![endif]><span style='font-family:Times'>A 25% EU royalty
to be paid to PBYI from Pierre Fabre<o:p></o:p></span></p>

<p class=MsoListParagraphCxSpMiddle style='text-indent:-.25in;mso-list:l0 level1 lfo1;
tab-stops:276.2pt'><![if !supportLists]><span style='font-family:Symbol;
mso-fareast-font-family:Symbol;mso-bidi-font-family:Symbol'><span
style='mso-list:Ignore'>·<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><![endif]><span style='font-family:Times'>$180M to be paid
to Pfizer for <span class=SpellE>Nerlynx</span> regulatory and
commercialization milestones<o:p></o:p></span></p>

<p class=MsoListParagraphCxSpMiddle style='text-indent:-.25in;mso-list:l0 level1 lfo1;
tab-stops:276.2pt'><![if !supportLists]><span style='font-family:Symbol;
mso-fareast-font-family:Symbol;mso-bidi-font-family:Symbol'><span
style='mso-list:Ignore'>·<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><![endif]><span style='font-family:Times'>$345M to be paid
to PBYI from Pierre Fabre for regulatory and commercialization milestones in
the EU<o:p></o:p></span></p>

<p class=MsoListParagraphCxSpMiddle style='text-indent:-.25in;mso-list:l0 level1 lfo1;
tab-stops:276.2pt'><![if !supportLists]><span style='font-family:Symbol;
mso-fareast-font-family:Symbol;mso-bidi-font-family:Symbol'><span
style='mso-list:Ignore'>·<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><![endif]><span style='font-family:Times'>0% tax rate<o:p></o:p></span></p>

<p class=MsoListParagraphCxSpLast style='text-indent:-.25in;mso-list:l0 level1 lfo1;
tab-stops:276.2pt'><![if !supportLists]><span style='font-family:Symbol;
mso-fareast-font-family:Symbol;mso-bidi-font-family:Symbol'><span
style='mso-list:Ignore'>·<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><![endif]><span style='font-family:Times'>Target forward
P/E ratio of 5x<o:p></o:p></span></p>

<p class=MsoNormal style='tab-stops:276.2pt'><span style='font-family:Times'><o:p>&nbsp;</o:p></span></p>

<p class=MsoNormal style='tab-stops:276.2pt'><span style='font-family:Times'>Using
these assumptions, we get expected net revenues of $545M. It’s worth pointing
out that this is much lower than previous peak sales estimates (for all
indications) of<span style='mso-spacerun:yes'>  </span></span><a
href="https://www.fiercepharma.com/financials/puma-s-breast-cancer-drug-nerlynx-to-command-10k-a-month-despite-concerns-report"><span
style='font-family:Times;text-decoration:none;text-underline:none'>$1B-$2B+</span></a><span
style='font-family:Times'>. But given that through April, management guided for
annual net sales of $230M, we think the lower end of our net sales probability
distribution of $170M seems conservative enough. <o:p></o:p></span></p>

<p class=MsoNormal style='tab-stops:276.2pt'><span style='font-family:Times'><o:p>&nbsp;</o:p></span></p>

<p class=MsoNormal style='tab-stops:276.2pt'><span style='font-family:Times'>Including
the $345M in potential regulatory and commercial milestones from Pierre Fabre
and subtracting the $180M estimated payment to Pfizer, we arrive at a PT of $26.27/share.
An expanded market size upon additional approvals in other variants of breast
cancer (and solid tumors) would unlock further value, as would a royalty rate
from Pierre Fabre that is higher than the 25% that we assume (remember that the
licensing deal called for “significant” double-digit royalties up to 40%).
Also, the upside might be even more should SGA costs eventually come down once
the salesforce is reduced after the initial roll-out. And RD costs, which are
going towards investigating other indications, might eventually decline. (Since
total assets are somewhat higher than total liabilities, we exclude these from
the calculation for simplicity.)<o:p></o:p></span></p>

<p class=MsoNormal style='tab-stops:276.2pt'><b style='mso-bidi-font-weight:
normal'><span style='font-size:14.0pt;font-family:Times'><o:p>&nbsp;</o:p></span></b></p>

<p class=MsoNormal align=center style='text-align:center;tab-stops:276.2pt'><b
style='mso-bidi-font-weight:normal'><span style='font-size:14.0pt;font-family:
Times'>PBYI: <span class=SpellE>Nerlynx</span> Peak Sales Estimates </span></b><b
style='mso-bidi-font-weight:normal'><span style='font-family:Times'>($M)</span></b><b
style='mso-bidi-font-weight:normal'><span style='font-size:14.0pt;font-family:
Times'><o:p></o:p></span></b></p>

<p class=MsoNormal align=center style='text-align:center;tab-stops:276.2pt'><b
style='mso-bidi-font-weight:normal'><span style='font-size:14.0pt;font-family:
Times'><o:p>&nbsp;</o:p></span></b></p>

<p class=MsoNormal align=center style='text-align:center;tab-stops:276.2pt'><b
style='mso-bidi-font-weight:normal'><span style='font-family:Times;mso-no-proof:
yes'><!--[if gte vml 1]><v:shape id="_x0000_i1030" type="#_x0000_t75" alt=""
 style='width:391pt;height:214pt;mso-width-percent:0;mso-height-percent:0;
 mso-width-percent:0;mso-height-percent:0' o:ole="">
 <v:imagedata src="PBYI%208E.fld/image010.emz" o:title=""/>
</v:shape><![endif]--><![if !vml]><img border=0 width=391 height=214
src="PBYI%208E.fld/image011.png" v:shapes="_x0000_i1030"><![endif]><!--[if gte mso 9]><xml>
 <o:OLEObject Type="Embed" ProgID="Excel.Sheet.12" ShapeID="_x0000_i1030"
  DrawAspect="Content" ObjectID="_1620805638">
 </o:OLEObject>
</xml><![endif]--></span></b><b style='mso-bidi-font-weight:normal'><span
style='font-family:Times'><o:p></o:p></span></b></p>

<p class=MsoNormal align=center style='text-align:center;tab-stops:276.2pt'><b
style='mso-bidi-font-weight:normal'><span style='font-family:Times'><o:p>&nbsp;</o:p></span></b></p>

<p class=MsoNormal align=center style='text-align:center;tab-stops:276.2pt'><b
style='mso-bidi-font-weight:normal'><span style='font-family:Times;mso-no-proof:
yes'><!--[if gte vml 1]><v:shape id="_x0000_i1029" type="#_x0000_t75" alt=""
 style='width:510pt;height:214pt;mso-width-percent:0;mso-height-percent:0;
 mso-width-percent:0;mso-height-percent:0' o:ole="">
 <v:imagedata src="PBYI%208E.fld/image012.emz" o:title=""/>
</v:shape><![endif]--><![if !vml]><img border=0 width=510 height=214
src="PBYI%208E.fld/image013.png" v:shapes="_x0000_i1029"><![endif]><!--[if gte mso 9]><xml>
 <o:OLEObject Type="Embed" ProgID="Excel.Sheet.12" ShapeID="_x0000_i1029"
  DrawAspect="Content" ObjectID="_1620805640">
 </o:OLEObject>
</xml><![endif]--></span></b><b style='mso-bidi-font-weight:normal'><span
style='font-family:Times'><o:p></o:p></span></b></p>

<p class=MsoNormal align=center style='text-align:center;tab-stops:276.2pt'><b
style='mso-bidi-font-weight:normal'><span style='font-family:Times'><o:p>&nbsp;</o:p></span></b></p>

<p class=MsoNormal align=center style='text-align:center;tab-stops:276.2pt'><b
style='mso-bidi-font-weight:normal'><span style='font-family:Times'><o:p>&nbsp;</o:p></span></b></p>

<p class=MsoNormal align=center style='text-align:center;tab-stops:276.2pt'><b
style='mso-bidi-font-weight:normal'><span style='font-family:Times;mso-no-proof:
yes'><!--[if gte vml 1]><v:shape id="_x0000_i1028" type="#_x0000_t75" alt=""
 style='width:391pt;height:214pt;mso-width-percent:0;mso-height-percent:0;
 mso-width-percent:0;mso-height-percent:0' o:ole="">
 <v:imagedata src="PBYI%208E.fld/image014.emz" o:title=""/>
</v:shape><![endif]--><![if !vml]><img border=0 width=391 height=214
src="PBYI%208E.fld/image015.png" v:shapes="_x0000_i1028"><![endif]><!--[if gte mso 9]><xml>
 <o:OLEObject Type="Embed" ProgID="Excel.Sheet.12" ShapeID="_x0000_i1028"
  DrawAspect="Content" ObjectID="_1620805641">
 </o:OLEObject>
</xml><![endif]--></span></b><b style='mso-bidi-font-weight:normal'><span
style='font-family:Times'><o:p></o:p></span></b></p>

<p class=MsoNormal align=center style='text-align:center;tab-stops:276.2pt'><b
style='mso-bidi-font-weight:normal'><span style='font-family:Times'><o:p>&nbsp;</o:p></span></b></p>

<p class=MsoNormal align=center style='text-align:center;tab-stops:276.2pt'><b
style='mso-bidi-font-weight:normal'><span style='font-family:Times;mso-no-proof:
yes'><!--[if gte vml 1]><v:shape id="_x0000_i1027" type="#_x0000_t75" alt=""
 style='width:391pt;height:214pt;mso-width-percent:0;mso-height-percent:0;
 mso-width-percent:0;mso-height-percent:0' o:ole="">
 <v:imagedata src="PBYI%208E.fld/image016.emz" o:title=""/>
</v:shape><![endif]--><![if !vml]><img border=0 width=391 height=214
src="PBYI%208E.fld/image017.png" v:shapes="_x0000_i1027"><![endif]><!--[if gte mso 9]><xml>
 <o:OLEObject Type="Embed" ProgID="Excel.Sheet.12" ShapeID="_x0000_i1027"
  DrawAspect="Content" ObjectID="_1620805642">
 </o:OLEObject>
</xml><![endif]--></span></b><b style='mso-bidi-font-weight:normal'><span
style='font-family:Times'><o:p></o:p></span></b></p>

<p class=MsoNormal style='tab-stops:276.2pt'><span style='font-family:Times'><o:p>&nbsp;</o:p></span></p>

<p class=MsoNormal align=center style='text-align:center;tab-stops:276.2pt'><span
style='font-size:10.0pt;font-family:Times'><o:p>&nbsp;</o:p></span></p>

<p class=MsoNormal align=center style='text-align:center;tab-stops:276.2pt'><span
style='font-size:10.0pt;font-family:Times;mso-no-proof:yes'><!--[if gte vml 1]><v:shape
 id="_x0000_i1026" type="#_x0000_t75" alt="" style='width:207pt;height:17pt;
 mso-width-percent:0;mso-height-percent:0;mso-width-percent:0;
 mso-height-percent:0' o:ole="">
 <v:imagedata src="PBYI%208E.fld/image018.emz" o:title=""/>
</v:shape><![endif]--><![if !vml]><img border=0 width=207 height=17
src="PBYI%208E.fld/image019.png" v:shapes="_x0000_i1026"><![endif]><!--[if gte mso 9]><xml>
 <o:OLEObject Type="Embed" ProgID="Excel.Sheet.12" ShapeID="_x0000_i1026"
  DrawAspect="Content" ObjectID="_1620805643">
 </o:OLEObject>
</xml><![endif]--></span><span style='font-size:10.0pt;font-family:Times'><o:p></o:p></span></p>

<p class=MsoNormal align=center style='text-align:center;tab-stops:276.2pt'><span
style='font-size:10.0pt;font-family:Times'>Sources: Elle Investments, PBYI
filings<o:p></o:p></span></p>

<p class=MsoNormal align=center style='text-align:center;tab-stops:276.2pt'><span
style='font-size:10.0pt;font-family:Times'><o:p>&nbsp;</o:p></span></p>

<p class=MsoNormal align=center style='text-align:center;tab-stops:276.2pt'><span
style='font-size:10.0pt;font-family:Times'><o:p>&nbsp;</o:p></span></p>

<p class=MsoNormal align=center style='text-align:center;tab-stops:276.2pt'><span
style='font-size:10.0pt;font-family:Times'><o:p>&nbsp;</o:p></span></p>

<p class=MsoNormal align=center style='text-align:center;tab-stops:276.2pt'><span
style='font-size:10.0pt;font-family:Times'><o:p>&nbsp;</o:p></span></p>

<p class=MsoNormal align=center style='text-align:center;tab-stops:276.2pt'><span
style='font-size:10.0pt;font-family:Times'><o:p>&nbsp;</o:p></span></p>

<p class=MsoNormal align=center style='text-align:center;tab-stops:276.2pt'><span
style='font-size:10.0pt;font-family:Times'><o:p>&nbsp;</o:p></span></p>

<p class=MsoNormal align=center style='text-align:center;tab-stops:276.2pt'><span
style='font-size:10.0pt;font-family:Times'><o:p>&nbsp;</o:p></span></p>

<p class=MsoNormal align=center style='text-align:center;tab-stops:276.2pt'><span
style='font-size:10.0pt;font-family:Times'><o:p>&nbsp;</o:p></span></p>

<p class=MsoNormal align=center style='text-align:center;tab-stops:276.2pt'><span
style='font-size:10.0pt;font-family:Times'><o:p>&nbsp;</o:p></span></p>

<p class=MsoNormal align=center style='text-align:center;tab-stops:276.2pt'><span
style='font-size:10.0pt;font-family:Times'><o:p>&nbsp;</o:p></span></p>

<p class=MsoNormal align=center style='text-align:center;tab-stops:276.2pt'><span
style='font-size:10.0pt;font-family:Times'><o:p>&nbsp;</o:p></span></p>

<p class=MsoNormal align=center style='text-align:center;tab-stops:276.2pt'><span
style='font-size:10.0pt;font-family:Times'><o:p>&nbsp;</o:p></span></p>

<p class=MsoNormal align=center style='text-align:center;tab-stops:276.2pt'><span
style='font-size:10.0pt;font-family:Times'><o:p>&nbsp;</o:p></span></p>

<p class=MsoNormal align=center style='text-align:center;tab-stops:276.2pt'><span
style='font-size:10.0pt;font-family:Times'><o:p>&nbsp;</o:p></span></p>

<p class=MsoNormal align=center style='text-align:center;tab-stops:276.2pt'><span
style='font-size:10.0pt;font-family:Times'><o:p>&nbsp;</o:p></span></p>

<p class=MsoNormal align=center style='text-align:center;tab-stops:276.2pt'><span
style='font-size:10.0pt;font-family:Times'><o:p>&nbsp;</o:p></span></p>

<p class=MsoNormal align=center style='text-align:center;tab-stops:276.2pt'><span
style='font-size:10.0pt;font-family:Times'><o:p>&nbsp;</o:p></span></p>

<p class=MsoNormal align=center style='text-align:center;tab-stops:276.2pt'><span
style='font-size:10.0pt;font-family:Times'><o:p>&nbsp;</o:p></span></p>

<p class=MsoNormal align=center style='text-align:center;tab-stops:276.2pt'><span
style='font-size:10.0pt;font-family:Times'><o:p>&nbsp;</o:p></span></p>

<p class=MsoNormal align=center style='text-align:center;tab-stops:276.2pt'><span
style='font-size:10.0pt;font-family:Times'><o:p>&nbsp;</o:p></span></p>

<p class=MsoNormal align=center style='text-align:center;tab-stops:276.2pt'><span
style='font-size:10.0pt;font-family:Times'><o:p>&nbsp;</o:p></span></p>

<p class=MsoNormal align=center style='text-align:center;tab-stops:276.2pt'><span
style='font-size:10.0pt;font-family:Times'><o:p>&nbsp;</o:p></span></p>

<p class=MsoNormal align=center style='text-align:center;tab-stops:276.2pt'><span
style='font-size:10.0pt;font-family:Times'><o:p>&nbsp;</o:p></span></p>

<p class=MsoNormal align=center style='text-align:center;tab-stops:276.2pt'><span
style='font-size:10.0pt;font-family:Times'><o:p>&nbsp;</o:p></span></p>

<p class=MsoNormal align=center style='text-align:center;tab-stops:276.2pt'><span
style='font-size:10.0pt;font-family:Times'><o:p>&nbsp;</o:p></span></p>

<p class=MsoNormal align=center style='text-align:center;tab-stops:276.2pt'><span
style='font-size:10.0pt;font-family:Times'><o:p>&nbsp;</o:p></span></p>

<p class=MsoNormal align=center style='text-align:center;tab-stops:276.2pt'><span
style='font-size:10.0pt;font-family:Times'><o:p>&nbsp;</o:p></span></p>

<p class=MsoNormal align=center style='text-align:center;tab-stops:276.2pt'><span
style='font-size:10.0pt;font-family:Times'><o:p>&nbsp;</o:p></span></p>

<p class=MsoNormal align=center style='text-align:center;tab-stops:276.2pt'><span
style='font-size:10.0pt;font-family:Times'><o:p>&nbsp;</o:p></span></p>

<p class=MsoNormal align=center style='text-align:center;tab-stops:276.2pt'><span
style='font-size:10.0pt;font-family:Times'><o:p>&nbsp;</o:p></span></p>

<p class=MsoNormal align=center style='text-align:center;tab-stops:276.2pt'><span
style='font-size:10.0pt;font-family:Times'><o:p>&nbsp;</o:p></span></p>

<p class=MsoNormal align=center style='text-align:center;tab-stops:276.2pt'><span
style='font-size:10.0pt;font-family:Times'><o:p>&nbsp;</o:p></span></p>

<p class=MsoNormal align=center style='text-align:center;tab-stops:276.2pt'><b
style='mso-bidi-font-weight:normal'><span style='font-size:14.0pt;font-family:
Times'>PBYI: Peak Year Price Target Estimate </span></b><b style='mso-bidi-font-weight:
normal'><span style='font-family:Times'>($M)</span></b><span style='font-size:
10.0pt;font-family:Times'><o:p></o:p></span></p>

<p class=MsoNormal align=center style='text-align:center;tab-stops:276.2pt'><span
style='font-size:10.0pt;font-family:Times'><o:p>&nbsp;</o:p></span></p>

<p class=MsoNormal align=center style='text-align:center;tab-stops:276.2pt'><span
style='font-size:10.0pt;font-family:Times;mso-no-proof:yes'><!--[if gte vml 1]><v:shape
 id="_x0000_i1025" type="#_x0000_t75" alt="" style='width:272pt;height:498pt;
 mso-width-percent:0;mso-height-percent:0;mso-width-percent:0;
 mso-height-percent:0' o:ole="">
 <v:imagedata src="PBYI%208E.fld/image020.emz" o:title=""/>
</v:shape><![endif]--><![if !vml]><img border=0 width=272 height=498
src="PBYI%208E.fld/image021.png" v:shapes="_x0000_i1025"><![endif]><!--[if gte mso 9]><xml>
 <o:OLEObject Type="Embed" ProgID="Excel.Sheet.12" ShapeID="_x0000_i1025"
  DrawAspect="Content" ObjectID="_1620805644">
 </o:OLEObject>
</xml><![endif]--></span><span style='font-size:10.0pt;font-family:Times'><o:p></o:p></span></p>

<p class=MsoNormal align=center style='text-align:center;tab-stops:276.2pt'><span
style='font-size:10.0pt;font-family:Times'>Sources: Elle Investments, PBYI
filings<o:p></o:p></span></p>

<p class=MsoNormal style='tab-stops:276.2pt'><span style='font-family:Times'><o:p>&nbsp;</o:p></span></p>

<p class=MsoNormal style='tab-stops:276.2pt'><span style='font-family:Times'><o:p>&nbsp;</o:p></span></p>

<p class=MsoNormal style='tab-stops:276.2pt'><b style='mso-bidi-font-weight:
normal'><span style='font-family:Times'>CONCLUSION:</span></b><span
style='font-family:Times'> <o:p></o:p></span></p>

<p class=MsoNormal style='tab-stops:276.2pt'><span style='font-family:Times'><o:p>&nbsp;</o:p></span></p>

<p class=MsoNormal style='tab-stops:276.2pt'><span style='font-family:Times'>After
1Q19 results, the possibility of <span class=SpellE>Nerlynx</span> reaching
blockbuster status is looking less likely. Still, even with considerably lower
peak sales estimates, the 50% sell-off post earnings <span class=GramE>offers</span>
68% upside to our new lower PT of $26.27/share. Additionally, if more patients
adhere to taking an anti-diarrheal to mitigate the severe diarrhea that <span
class=SpellE>Nerlynx</span> causes, the upside would be considerably more. <span
style='mso-spacerun:yes'> </span><o:p></o:p></span></p>

<p class=MsoNormal style='tab-stops:276.2pt'><span style='font-family:Times'><o:p>&nbsp;</o:p></span></p>

<p class=MsoNormal style='tab-stops:276.2pt'><span style='font-family:Times'><o:p>&nbsp;</o:p></span></p>

<p class=MsoNormal style='tab-stops:276.2pt'><b style='mso-bidi-font-weight:
normal'><span style='font-family:Times'>GLOSSARY:</span></b><span
style='font-family:Times'> <o:p></o:p></span></p>

<p class=MsoNormal style='tab-stops:276.2pt'><span style='font-family:Times'>HER2+:
human epidermal growth factor receptor 2 positive<o:p></o:p></span></p>

<p class=MsoNormal style='tab-stops:276.2pt'><span style='font-family:Times'>HR+:
hormone receptor positive<o:p></o:p></span></p>

<p class=MsoNormal style='tab-stops:276.2pt'><span style='font-family:Times'>MBC:
metastatic breast cancer<o:p></o:p></span></p>

<p class=MsoNormal style='tab-stops:276.2pt'><span style='font-family:Times'><o:p>&nbsp;</o:p></span></p>

<p class=MsoNormal style='tab-stops:276.2pt'><span style='font-family:Times'><o:p>&nbsp;</o:p></span></p>

<p class=MsoNormal style='tab-stops:276.2pt'><i style='mso-bidi-font-style:
normal'><span style='font-family:Times'>Note: Additional commentary from Elle
Investments can also be found at </span></i><a
href="http://elle-investments.com"><i style='mso-bidi-font-style:normal'><span
style='font-family:Times'>http://elle-investments.com</span></i></a><i
style='mso-bidi-font-style:normal'><span style='font-family:Times'>. We welcome
your feedback. Additionally, we are thinking of launching a subscription
service that would offer early access to our research, along with some other
features that investors might find useful (i.e. general portfolio management
strategies, live blog updates highlighting our reaction to breaking news,
etc.). If you would be interested in subscribing to such a service, please let
us know.<o:p></o:p></span></i></p>

<p class=MsoNormal style='tab-stops:276.2pt'><i style='mso-bidi-font-style:
normal'><span style='font-family:Times'><o:p>&nbsp;</o:p></span></i></p>

<p class=MsoNormal style='tab-stops:276.2pt'><i style='mso-bidi-font-style:
normal'><span style='font-family:Times'>Published By: Elle Investments Research
Team<o:p></o:p></span></i></p>

<p class=MsoNormal style='tab-stops:276.2pt'><i style='mso-bidi-font-style:
normal'><span style='font-family:Times'>Phone: (914) 715-8066<o:p></o:p></span></i></p>

<p class=MsoNormal style='tab-stops:276.2pt'><i style='mso-bidi-font-style:
normal'><span style='font-family:Times'>Email: info@elle-investments.com<o:p></o:p></span></i></p>

<p class=MsoNormal style='tab-stops:276.2pt'><span style='font-family:Times'><o:p>&nbsp;</o:p></span></p>

<p class=MsoNormal style='tab-stops:276.2pt'><i style='mso-bidi-font-style:
normal'><span style='font-family:Times'>Disclaimer: The Elle Investments
portfolio is managed utilizing a “<span class=SpellE>quantamental</span>”
approach where each position, while based on Fundamental Analysis, is sized as
part of a larger quantitative portfolio. The commentary presented here is for
research purposes only and is not to be taken as investment advice. Readers are
expected to perform their own due diligence and/or hire an investment
professional prior to entering/exiting positions. Published research ideas are
related to the specific market price and publicly available information at the
time of research submission/publication. Elle Investments will enter/exit
positions without notice.<o:p></o:p></span></i></p>

<p class=MsoNormal style='tab-stops:276.2pt'><span style='font-family:Times'><o:p>&nbsp;</o:p></span></p>

<p class=MsoNormal style='tab-stops:276.2pt'><i style='mso-bidi-font-style:
normal'><span style='font-family:Times'><o:p>&nbsp;</o:p></span></i></p>

<p class=MsoNormal style='tab-stops:276.2pt'><i style='mso-bidi-font-style:
normal'><span style='font-family:Times'><o:p>&nbsp;</o:p></span></i></p>

<p class=MsoNormal style='tab-stops:276.2pt'><span style='font-family:Times'><o:p>&nbsp;</o:p></span></p>

<p class=MsoNormal style='tab-stops:276.2pt'><span style='font-family:Times'><o:p>&nbsp;</o:p></span></p>

</div>

</body>

</html>
